Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 93 (1), 34-50

Endocrine Disrupting Chemicals and the Developmental Programming of Adipogenesis and Obesity

Affiliations
Review

Endocrine Disrupting Chemicals and the Developmental Programming of Adipogenesis and Obesity

Amanda Janesick et al. Birth Defects Res C Embryo Today.

Abstract

Obesity and related disorders are a burgeoning public health epidemic, particularly in the U.S. Currently 34% of the U.S. population is clinically obese (BMI > 30) and 68% are overweight (BMI > 25), more than double the worldwide average and 10-fold higher than Japan and South Korea. Obesity occurs when energy intake exceeds energy expenditure; however, individuals vary widely in their propensity to gain weight and accrue fat mass, even at identical levels of excess caloric input. Clinical, epidemiological, and biological studies show that obesity is largely programmed during early life, including the intrauterine period. The environmental obesogen hypothesis holds that prenatal or early life exposure to certain endocrine disrupting chemicals can predispose exposed individuals to increased fat mass and obesity. Obesogen exposure can alter the epigenome of multipotent stromal stem cells, biasing them toward the adipocyte lineage at the expense of bone. Hence, humans exposed to obesogens during early life might have an altered stem cell compartment, which is preprogrammed toward an adipogenic fate. This results in a higher steady state number of adipocytes and potentially a lifelong struggle to maintain a healthy weight, which can be exacerbated by societal influences that promote poor diet and inadequate exercise. This review focuses on the developmental origins of the adipocyte, the relationship between adipocyte number and obesity, and how obesogenic chemicals may interfere with the highly efficient homeostatic mechanisms regulating adipocyte number and energy balance.

Figures

Figure 1
Figure 1
Depiction of the three classical somatotypes (from left to right): ectomorph, mesomorph, and endomorph.
Figure 2
Figure 2
Diagram of the potential interactions of endocrine disrupting chemicals during various stages of adipose tissue development.

Similar articles

  • Obesogens, Stem Cells and the Developmental Programming of Obesity
    A Janesick et al. Int J Androl 35 (3), 437-48. PMID 22372658. - Review
    Obesogens are chemicals that directly or indirectly lead to increased fat accumulation and obesity. Obesogens have the potential to disrupt multiple metabolic signalling …
  • Obesogens: An Emerging Threat to Public Health
    AS Janesick et al. Am J Obstet Gynecol 214 (5), 559-65. PMID 26829510. - Review
    Endocrine disrupting chemicals (EDCs) are defined as exogenous chemicals, or mixtures of chemicals, that can interfere with any aspect of hormone action. The field of end …
  • Endocrine Disruptors and Obesity
    PD Darbre. Curr Obes Rep 6 (1), 18-27. PMID 28205155. - Review
    Recent findings demonstrate that such endocrine-disrupting chemicals, termed "obesogens", can promote adipogenesis and cause weight gain. This includes compounds to which …
  • Minireview: PPARγ as the Target of Obesogens
    A Janesick et al. J Steroid Biochem Mol Biol 127 (1-2), 4-8. PMID 21251979. - Review
    The peroxisome proliferator-activated receptor gamma (PPARγ) is a key regulator of adipogenesis and is medically important for its connections to obesity and the treatmen …
  • Endocrine Disruptors and Obesity
    JJ Heindel et al. Nat Rev Endocrinol 11 (11), 653-61. PMID 26391979. - Review
    The increasing incidence of obesity is a serious global public health challenge. Although the obesity epidemic is largely fueled by poor nutrition and lack of exercise, c …
See all similar articles

Cited by 75 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback